Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake

NCT03962101 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure

Interventions

DRUG: OPC-61815 injection

Sponsor

Otsuka Pharmaceutical Co., Ltd.